© Copyright - Newspaper WordPress Theme by TagDiv
Tiotropium Bromide
Also known as / Synonyms: Tiotropium Bromide Monohydrate, LAMA
Long-acting muscarinic antagonist (LAMA) inhaler providing 24-hour bronchodilation for COPD and severe asthma.
Clinical Snapshot & Specifications
Approved Indications & Medical Uses
- Long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
- Reduction of COPD exacerbations.
- Add-on maintenance bronchodilator treatment in patients 6 years and older with severe asthma who experience symptoms despite ICS/LABA therapy.
Contraindications (Do Not Use If…)
- History of hypersensitivity to tiotropium, ipratropium, or formulation components.
- History of severe allergy to milk proteins (dry powder capsules contain lactose excipients).
Important Clinical Precautions & Warnings
- Not for acute bronchospasm: tiotropium is a once-daily maintenance medication and must not be used as rescue therapy for acute respiratory attacks.
- Paradoxical bronchospasm: may occur; treat immediately with an inhaled short-acting beta-agonist and discontinue tiotropium.
- Narrow-angle glaucoma: use with caution; direct accidental eye exposure may cause pupillary dilation, angle closure, and acute ocular pain.
- Urinary retention: use with caution in patients with prostatic hyperplasia or bladder neck obstruction.
- Renal impairment: patients with moderate-to-severe renal impairment (CrCl <= 50 mL/min) should be monitored closely for anticholinergic side effects.
Special Populations (Paediatric & Geriatric Care)
Pediatric: Approved for asthma maintenance in patients >= 6 years; not indicated for pediatric COPD. Geriatric: No overall differences in efficacy or safety observed; renal clearance decreases with age.
Side Effects & Adverse Reactions
Common Side Effects (Usually Mild)
Dry mouth (most common), upper respiratory tract infection, pharyngitis, sinusitis, headache, constipation, and cough.
Serious Side Effects — Seek Urgent Medical Care
Acute narrow-angle glaucoma, severe urinary retention, paradoxical bronchospasm, cardiac arrhythmias (supraventricular tachycardia, atrial fibrillation), and angioedema.
Action: Discontinue medication and seek immediate medical attention or call emergency services if any serious symptom occurs.
Drug, Food & Substance Interactions
- Other anticholinergic drugs (ipratropium, aclidinium, umeclidinium): additive anticholinergic effects and toxicity; avoid concomitant use.
- Beta-agonists and corticosteroids: safe and commonly co-administered as part of dual or triple inhaler regimens in COPD.
Pregnancy & Lactation Clinical Safety
Pregnancy Safety:
Use with caution — see notesThere are no adequate and well-controlled studies in pregnant women. Animal studies showed no teratogenicity. Use during pregnancy only if the potential benefit justifies potential fetal risk.
Lactation & Breastfeeding:
Use with caution — see notesExcretion in human breast milk is unknown. Because tiotropium binds poorly to systemic circulation and achieves low plasma concentrations, small amounts are expected, but caution is advised.
Storage, Administration & Overdose Protocol
🌡️ Recommended Storage:
Store rotacaps in original blister pack at 20°C to 25°C (68°F to 77°F). Protect from moisture. Never swallow capsules orally; inhale via the designated inhaler device.
⏱️ Missed Dose Protocol:
Take the missed once-daily inhalation as soon as remembered, but do not take more than one dose in a single 24-hour period.
High doses of tiotropium can produce exaggerated anticholinergic signs: severe dry mouth, blurred vision, urinary retention, constipation, and tachycardia. Severe systemic intoxication is rare due to poor systemic oral bioavailability.
